Le Lézard
Classified in: Health
Subject: SVY

Global cell therapy market is expected to grow with a healthy CAGR over the forecast period from 2019-2025


The report on the global cell therapy market provides qualitative and quantitative analysis for the period from 2017 to 2025.

Read the full report: https://www.reportlinker.com/p05796546/?utm_source=PRN

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- The report predicts the global cell therapy market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on cell therapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on cell therapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cell therapy market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cell therapy market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
? Increasing incidences of cancer across the globe
? Growing aging patient population
? Rise in cell therapy transplantations
2) Restraints
? The high cost of transplantation treatment
? Stringent regulatory policies
3) Opportunities
? Automation in cell therapy

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global cell therapy market is segmented on the basis of cell type, therapy type, application, and end-users.

The Global Cell Therapy Market by Cell Type
? Stem Cell
? Differentiated Cell

The Global Cell Therapy Market by Therapy Type
? Allogenic Therapies
? Autologous Therapies

The Global Cell Therapy Market by Application
? Autoimmune Diseases
? Oncology
? Dermatology
? Muscoskeletal Therapies
? Other Applications

The Global Cell Therapy Market by End-Users
? Hospitals and Clinics
? Biotechnology and Pharmaceutical Companies
? Research Institutes

Company Profiles
? NuVasive, Inc
? Kolon TissueGene, Inc.
? JCR Pharmaceuticals Co., Ltd.
? Osiris Therapeutics, Inc.
? Stemedica Cell Technologies, Inc.
? MEDIPOST
? Celgene Corporation
? ANTEROGEN.CO., LTD
? Vericel Corporation

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the cell therapy market.
2. Complete coverage of all the segments in the cell therapy market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global cell therapy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Read the full report: https://www.reportlinker.com/p05796546/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 11:35
The Bone Health and Osteoporosis Foundation (BHOF) announced today its call for nominees for the newly created Robert F. Gagel, M.D. Community Leadership Award. The award's intent is to recognize healthcare professionals who are instrumental in...

at 11:33
Celebrating the 40th anniversary of The Glaucoma Foundation, writer, performer and producer David Letterman was front and center at TGF's April 18th Gala in New York City, where he received the Foundation's inaugural Chairman's Spotlight Award....

at 11:30
CancerIQ, a best-in-class cancer-focused precision health platform, today announced it is seeking health systems to participate in the newly launched, large-scale research effort that will document...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 11:00
PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam's appointment follows an extensive...



News published on and distributed by: